KR101119645B1 - A functional beverage composition comprising deep sea water, taurine, vitamins, royal jelly and propolis as main ingredients - Google Patents
A functional beverage composition comprising deep sea water, taurine, vitamins, royal jelly and propolis as main ingredients Download PDFInfo
- Publication number
- KR101119645B1 KR101119645B1 KR1020090017371A KR20090017371A KR101119645B1 KR 101119645 B1 KR101119645 B1 KR 101119645B1 KR 1020090017371 A KR1020090017371 A KR 1020090017371A KR 20090017371 A KR20090017371 A KR 20090017371A KR 101119645 B1 KR101119645 B1 KR 101119645B1
- Authority
- KR
- South Korea
- Prior art keywords
- vitamin
- functional beverage
- juice
- beverage composition
- extract
- Prior art date
Links
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 title claims abstract description 42
- 229940088594 vitamin Drugs 0.000 title claims abstract description 32
- 229930003231 vitamin Natural products 0.000 title claims abstract description 32
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 32
- 239000011782 vitamin Substances 0.000 title claims abstract description 32
- 235000020510 functional beverage Nutrition 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 241000241413 Propolis Species 0.000 title claims abstract description 25
- 229940069949 propolis Drugs 0.000 title claims abstract description 25
- 229940109850 royal jelly Drugs 0.000 title claims abstract description 22
- 229960003080 taurine Drugs 0.000 title claims abstract description 21
- 239000013535 sea water Substances 0.000 title abstract description 51
- 239000002075 main ingredient Substances 0.000 title description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 42
- 229910052751 metal Inorganic materials 0.000 claims abstract description 17
- 239000002184 metal Substances 0.000 claims abstract description 17
- 150000007524 organic acids Chemical class 0.000 claims abstract description 17
- 150000003839 salts Chemical class 0.000 claims abstract description 17
- 229930091371 Fructose Natural products 0.000 claims abstract description 15
- 239000005715 Fructose Substances 0.000 claims abstract description 15
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 15
- 235000015203 fruit juice Nutrition 0.000 claims abstract description 11
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 7
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229940013618 stevioside Drugs 0.000 claims abstract description 7
- 235000019202 steviosides Nutrition 0.000 claims abstract description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 22
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 14
- 239000004615 ingredient Substances 0.000 claims description 13
- 239000011734 sodium Substances 0.000 claims description 13
- 235000005152 nicotinamide Nutrition 0.000 claims description 11
- 239000011570 nicotinamide Substances 0.000 claims description 11
- 229910052708 sodium Inorganic materials 0.000 claims description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 10
- 229960002477 riboflavin Drugs 0.000 claims description 10
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- 229940093915 gynecological organic acid Drugs 0.000 claims description 8
- 235000005985 organic acids Nutrition 0.000 claims description 8
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 8
- 239000004034 viscosity adjusting agent Substances 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 7
- 229930003471 Vitamin B2 Natural products 0.000 claims description 7
- 239000004310 lactic acid Chemical class 0.000 claims description 7
- 235000014655 lactic acid Nutrition 0.000 claims description 7
- 235000019164 vitamin B2 Nutrition 0.000 claims description 7
- 239000011716 vitamin B2 Substances 0.000 claims description 7
- 229930003779 Vitamin B12 Natural products 0.000 claims description 6
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 235000019163 vitamin B12 Nutrition 0.000 claims description 6
- 239000011715 vitamin B12 Substances 0.000 claims description 6
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 235000000346 sugar Nutrition 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- 235000004936 Bromus mango Nutrition 0.000 claims description 4
- 240000006432 Carica papaya Species 0.000 claims description 4
- 235000009467 Carica papaya Nutrition 0.000 claims description 4
- 235000005979 Citrus limon Nutrition 0.000 claims description 4
- 244000131522 Citrus pyriformis Species 0.000 claims description 4
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 4
- 240000009088 Fragaria x ananassa Species 0.000 claims description 4
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 4
- 240000007228 Mangifera indica Species 0.000 claims description 4
- 235000014826 Mangifera indica Nutrition 0.000 claims description 4
- 235000009184 Spondias indica Nutrition 0.000 claims description 4
- 235000015197 apple juice Nutrition 0.000 claims description 4
- LPNBBFKOUUSUDB-UHFFFAOYSA-N p-toluic acid Chemical compound CC1=CC=C(C(O)=O)C=C1 LPNBBFKOUUSUDB-UHFFFAOYSA-N 0.000 claims description 4
- 229930003799 tocopherol Natural products 0.000 claims description 4
- 229960001295 tocopherol Drugs 0.000 claims description 4
- 235000010384 tocopherol Nutrition 0.000 claims description 4
- 239000011732 tocopherol Substances 0.000 claims description 4
- 235000019159 vitamin B9 Nutrition 0.000 claims description 4
- 239000011727 vitamin B9 Substances 0.000 claims description 4
- 229940011671 vitamin b6 Drugs 0.000 claims description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical class CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- 229920002148 Gellan gum Polymers 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 229920002907 Guar gum Polymers 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- 229930003448 Vitamin K Natural products 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 3
- 239000011666 cyanocobalamin Substances 0.000 claims description 3
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 229960002061 ergocalciferol Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 235000010492 gellan gum Nutrition 0.000 claims description 3
- 239000000216 gellan gum Substances 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 229940065115 grapefruit extract Drugs 0.000 claims description 3
- 239000000665 guar gum Substances 0.000 claims description 3
- 235000010417 guar gum Nutrition 0.000 claims description 3
- 229960002154 guar gum Drugs 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 229960004488 linolenic acid Drugs 0.000 claims description 3
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 235000008160 pyridoxine Nutrition 0.000 claims description 3
- 239000011677 pyridoxine Substances 0.000 claims description 3
- 235000019192 riboflavin Nutrition 0.000 claims description 3
- 239000002151 riboflavin Substances 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000001892 vitamin D2 Nutrition 0.000 claims description 3
- 239000011653 vitamin D2 Substances 0.000 claims description 3
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 235000019168 vitamin K Nutrition 0.000 claims description 3
- 239000011712 vitamin K Substances 0.000 claims description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 229940046010 vitamin k Drugs 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- ZQVKTHRQIXSMGY-UHFFFAOYSA-N 4-Ethylbenzoic acid Chemical compound CCC1=CC=C(C(O)=O)C=C1 ZQVKTHRQIXSMGY-UHFFFAOYSA-N 0.000 claims description 2
- ATZHGRNFEFVDDJ-UHFFFAOYSA-N 4-propylbenzoic acid Chemical compound CCCC1=CC=C(C(O)=O)C=C1 ATZHGRNFEFVDDJ-UHFFFAOYSA-N 0.000 claims description 2
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930003756 Vitamin B7 Natural products 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 235000015201 grapefruit juice Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 235000015205 orange juice Nutrition 0.000 claims description 2
- 235000013944 peach juice Nutrition 0.000 claims description 2
- -1 sodium alkali metals Chemical class 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- 235000013948 strawberry juice Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 150000005846 sugar alcohols Polymers 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims description 2
- 235000011912 vitamin B7 Nutrition 0.000 claims description 2
- 239000011735 vitamin B7 Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 229930003451 Vitamin B1 Natural products 0.000 claims 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims 1
- 229960003495 thiamine Drugs 0.000 claims 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 1
- 235000010374 vitamin B1 Nutrition 0.000 claims 1
- 239000011691 vitamin B1 Substances 0.000 claims 1
- 235000019158 vitamin B6 Nutrition 0.000 claims 1
- 239000011726 vitamin B6 Substances 0.000 claims 1
- 235000002639 sodium chloride Nutrition 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 12
- 239000007788 liquid Substances 0.000 abstract description 12
- 239000001509 sodium citrate Substances 0.000 abstract description 11
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract description 11
- 235000007119 Ananas comosus Nutrition 0.000 abstract description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 10
- 235000003599 food sweetener Nutrition 0.000 abstract description 10
- 239000003765 sweetening agent Substances 0.000 abstract description 10
- 210000004185 liver Anatomy 0.000 abstract description 7
- 238000011084 recovery Methods 0.000 abstract description 6
- 239000011780 sodium chloride Substances 0.000 abstract description 6
- 230000002929 anti-fatigue Effects 0.000 abstract description 5
- 235000011187 glycerol Nutrition 0.000 abstract description 5
- 229940107702 grapefruit seed extract Drugs 0.000 abstract description 5
- 230000036737 immune function Effects 0.000 abstract description 5
- 230000003908 liver function Effects 0.000 abstract description 5
- 244000099147 Ananas comosus Species 0.000 abstract description 4
- 230000003712 anti-aging effect Effects 0.000 abstract description 4
- 210000000941 bile Anatomy 0.000 abstract description 4
- 238000001784 detoxification Methods 0.000 abstract description 4
- 235000021321 essential mineral Nutrition 0.000 abstract description 3
- 230000035876 healing Effects 0.000 abstract description 3
- 230000028327 secretion Effects 0.000 abstract description 3
- 235000012054 meals Nutrition 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 26
- 235000010755 mineral Nutrition 0.000 description 26
- 239000011707 mineral Substances 0.000 description 26
- 239000011575 calcium Substances 0.000 description 15
- 230000003078 antioxidant effect Effects 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 13
- 229910052791 calcium Inorganic materials 0.000 description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 12
- 229930003268 Vitamin C Natural products 0.000 description 12
- 235000019154 vitamin C Nutrition 0.000 description 12
- 239000011718 vitamin C Substances 0.000 description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 11
- 239000003963 antioxidant agent Substances 0.000 description 11
- 235000006708 antioxidants Nutrition 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 239000011777 magnesium Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 230000002354 daily effect Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 229910052749 magnesium Inorganic materials 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- 241000234671 Ananas Species 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000011669 selenium Substances 0.000 description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 5
- 229930003270 Vitamin B Natural products 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229960003966 nicotinamide Drugs 0.000 description 5
- 235000013997 pineapple juice Nutrition 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 229910052711 selenium Inorganic materials 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 235000019156 vitamin B Nutrition 0.000 description 5
- 239000011720 vitamin B Substances 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 241000257303 Hymenoptera Species 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000011572 manganese Substances 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 229940046664 taurine 500 mg Drugs 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- 208000007101 Muscle Cramp Diseases 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000003749 cleanliness Effects 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000005868 electrolysis reaction Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000001223 reverse osmosis Methods 0.000 description 3
- 208000007442 rickets Diseases 0.000 description 3
- 239000002352 surface water Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 208000016261 weight loss Diseases 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 2
- 230000002407 ATP formation Effects 0.000 description 2
- 241000256837 Apidae Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010061291 Mineral deficiency Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000028017 Psychotic disease Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000007961 artificial flavoring substance Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000002977 intracellular fluid Anatomy 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 208000005368 osteomalacia Diseases 0.000 description 2
- 230000004203 pancreatic function Effects 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 229940048003 royal jelly 100 mg Drugs 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 229940023356 vitamin b6 10 mg Drugs 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003805 Autism Diseases 0.000 description 1
- 208000020706 Autistic disease Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 206010027951 Mood swings Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000013612 Parathyroid disease Diseases 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000021403 cultural food Nutrition 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004578 fetal growth Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000010220 ion permeability Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000011738 major mineral Substances 0.000 description 1
- 235000011963 major mineral Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229940045613 taurine 1000 mg Drugs 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/032—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0644—Taurine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/24—Non-sugar sweeteners
- A23V2250/262—Stevioside
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/606—Fructose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/61—Glucose, Dextrose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/616—Maltose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/64—Sugar alcohols
- A23V2250/642—Sorbitol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/64—Sugar alcohols
- A23V2250/6422—Xylitol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/7042—Vitamin B1
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/7044—Vitamin B2
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/7052—Vitamin B6
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/706—Vitamin B12
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/708—Vitamin C
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/71—Vitamin D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/712—Vitamin E
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/714—Vitamin K
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/716—Vitamin M
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
본 발명은 탈염 해양심층수에 타우린, 비타민류, 로얄제리 및 프로폴리스를 주성분으로 함유하는 기능성 음료 조성물에 관한 것이다. 본 발명은 여기에 구연산, 자몽종자추출물, 구연산나트륨, 액상과당, 스테비오사이드, 염화나트륨, 파인애플후레바, 감미제, 유기산 또는 그 금속염, 글리세린, 점도 조절제, 향료, 과일주스에서 선택된 1종 이상의 성분을 더 함유할 수도 있다. 본 발명의 기능성 음료 조성물은 통상의 식사로는 부족하기 쉬운 필수 미네랄성분 등을 공급하고 간장의 활동을 촉진시키고. 담즙 분비를 활발히 하고 간장의 해독작용을 돕고, 간기능을 활성화 시키며 스트레스 해소, 자연 치유력 및 면역기능 증강, 항노화 작용, 피로회복 등의 효과를 가진다.The present invention relates to a functional beverage composition containing taurine, vitamins, royal jelly and propolis as a main component in desalted deep sea water. The present invention further comprises at least one component selected from citric acid, grapefruit seed extract, sodium citrate, liquid fructose, stevioside, sodium chloride, pineapple freva, sweetener, organic acid or metal salt thereof, glycerin, viscosity regulator, flavoring, fruit juice It may contain. The functional beverage composition of the present invention supplies essential minerals and the like which are not easily provided by ordinary meals and promotes the activity of the liver. It stimulates bile secretion, helps detoxification of liver, activates liver function, relieves stress, enhances natural healing and immune function, anti-aging and fatigue recovery.
기능성 음료 조성물, 해양심층수, 타우린, 비타민류, 로얄제리, 프로폴리스 Functional beverage composition, deep sea water, taurine, vitamins, royal jelly, propolis
Description
본 발명은 해양심층수, 비타민류, 타우린, 로얄제리 및 프로폴리스을 주성분으로 함유하는 기능성 음료 조성물에 관한 것이다.The present invention relates to a functional beverage composition containing the deep sea water, vitamins, taurine, royal jelly and propolis as a main component.
특히 본 발명은 주성분으로서 해양심층수, 비타민류, 타우린, 로얄제리 및 프로폴리스를 주성분으로 함유하고, 보조성분으로서 구연산, 구연산나트륨, 자몽종자추출물, 염화나트륨, 파인애플후레바, 스테비오사이드, 액상과당에서 선택된 1종 이상의 성분을 함유하는 것을 특징으로 하며, 특히 음용시 체내흡수가 빠르고 인체 체액과 유사한 미네랄이 골고루 함유된 해양심층수로 되어있어 무기성분인 나트륨, 칼슘, 마그네슘, 칼륨 등과 항암성분인 셀레늄, 아연성분이 풍부하여 체내흡수 및 활성화를 촉진시켜줌으로서 자연 치유력 및 면역기능 증강, 항노화 작용, 피로회복, 간기능 개선과 증강 등 건강유지에 도움을 주는 것을 특징으로 하는 기능성 음료 조성물을 제공하는 것이다.In particular, the present invention contains the deep sea water, vitamins, taurine, royal jelly and propolis as a main component, and selected from citric acid, sodium citrate, grapefruit seed extract, sodium chloride, pineapple freva, stevioside, liquid fructose as auxiliary components Characterized by containing one or more components, especially in the deep sea water containing fast absorption of the body and evenly containing minerals similar to human body fluid when drinking, selenium, zinc and other anticancer components such as sodium, calcium, magnesium, potassium It is rich in ingredients to promote the body absorption and activation to provide a functional beverage composition characterized in that it helps to maintain health, such as natural healing power and immune function enhancement, anti-aging action, fatigue recovery, liver function improvement and enhancement.
인체는 영양의 3대요소인 단백질, 전분질, 지질과 비타민류 등의 기본 영양을 필요로 하지만 소량의 미네랄도 필요로 하는 것으로 알려져 있다. 근래의 음식문화는 고단백에 비타민을 첨가한 음식이 발달해 있으므로 미네랄이 결핍될 확률이 많으며, 미네랄이 결핍될 경우, 여러 가지 결핍증상이 발생하게 된다.The human body needs basic nutrition such as protein, starch, lipids and vitamins, which are the three major elements of nutrition, but it is also known to require a small amount of minerals. In recent years, the food culture has high protein, vitamin-added food has a high probability of mineral deficiency, and if the mineral deficiency, various deficiency symptoms will occur.
필수적인 미네랄의 결핍증과 효능을 살펴보면, 먼저 구리(Cu)는 체내에서 효소를 비롯한 여러 단백질의 한 부분으로서 존재하는 필수적인 미량원소로서, 저장된 철분과 장관내의 철분을 헤모글로빈 생성장소로 운반하는 역할을 하고, 또는 미토콘드리아내 전자전달계의 마지막 과정에 작용하여 ATP(adenosine triphosphate) 생성에 관여하고, 또한 골격성과 심장 순환계의 결합조직을 정상으로 유지하는 데에도 기여하고, 단독 또는 아연과 함께 항산화효소인 SOD(Superoxide Dismutase)에 결합되어 세포의 산화적 손상을 방지하는 역할도 한다. 결핍시에는 빈혈, 백혈구 감소, 호중구 감소가 일어나게 되며, 효능으로는 심장혈관질환 예방, 관절염 치료, 산화방지 기능 및 항염증 효과를 볼 수 있으며, 일일 권장량은 1.5 내지 3.0mg/일이다.In view of the deficiency and efficacy of essential minerals, first, Cu is an essential trace element that exists as part of several proteins, including enzymes, in the body, which transports stored iron and intestinal iron to hemoglobin production sites. Or it acts on the final process of the electron transport system in the mitochondria and is involved in the production of ATP (adenosine triphosphate), and also contributes to maintaining the connective tissues of the skeletal and cardiac circulation normal, and the antioxidant enzyme SOD (Superoxide) alone or in combination with zinc Dismutase) also prevents oxidative damage to cells. When deficient, anemia, leukocyte reduction, neutrophil reduction occurs, and as an effect, cardiovascular disease prevention, arthritis treatment, antioxidant function, and anti-inflammatory effect can be seen, and the recommended daily dose is 1.5 to 3.0 mg / day.
나트륨(Na)는 세포외액의 중요한 성분으로서, 염소이온과 중탄산이온과 함께 인체의 산염기평형을 유지하고, 체액의 삼투압유지 및 체액량을 결정하는데 중요한 역할을 하며, 결핍시에는 심신이 허약하고 근육경련, 체중감소, 두통 및 불면을 유발되며, 효능으로는 정상 체액유지와 공급, 인체의 정상적인 산염기 균형유지, 정상적인 근육반응 유지 또는 정상적인 삼투압 유지 효과를 볼 수 있고, 1일 권장량은 10g 이하이나 한국인은 보통 10 내지 30g을 섭취한다.Sodium (Na) is an important component of extracellular fluid, along with chlorine and bicarbonate ions, plays an important role in maintaining the acid-base equilibrium of the body, maintaining the osmotic pressure of body fluids, and determining the amount of fluid. It can cause cramps, weight loss, headaches, and insomnia.Its effects include maintaining and supplying normal fluids, maintaining the normal acid balance of the human body, maintaining normal muscle reactions, or maintaining normal osmotic pressure. Koreans usually consume 10 to 30 grams.
마그네슘(Mg)은 인체내에 약 20 내지 28g이 존재하며, 약 60%가 뼈, 26%는 근육, 나머지는 연조직과 체액에 있으며, 세포내액의 중요한 구성성분으로서, 결핍시에는 신장 결석같은 신장 질환, 갑상선 기능 항진증, 급성 알코올중독증, 부갑상선장애, 근육경련 등이 유발되며, 효능으로는 당질대사, 지질대사, 단백질 대사와 핵산의 합성분해, 체내의 인지질(레시틴)의 합성을 돕고, 비타민C, B 복합체, 인, 나트륨, 칼륨 및 칼슘의 대사를 보조하고 신경 계통의 흥분 진정 효과를 불 수 있으며, 1일 권장량은 300mg이다.Magnesium (Mg) is present in the body of about 20 to 28g, about 60% in bone, 26% in muscle, the rest in soft tissues and body fluids, an important component of intracellular fluid, kidney disease, such as kidney stones when deficient , Hyperthyroidism, acute alcoholism, parathyroid disorders, muscle spasms, etc., and the effects are: carbohydrate metabolism, lipid metabolism, protein metabolism and synthesis of nucleic acids, help the synthesis of phospholipids (lecithin) in the body, vitamin C, It can aid in the metabolism of B complex, phosphorus, sodium, potassium and calcium, and stimulate the nervous system's excitement and calming effects. The recommended daily dose is 300 mg.
망간(Mn)은 여러 가지 효소의 활성화 작용에 기여하며, 결핍시에는 체중감소, 피부염, 오심 또는 구토, 머리칼 변색, 생식능력 저하 또는 췌장기능 저하로 인한 당뇨 증상이 유발되며, 효능으로는 노이로제, 조울증 또는 정신분열증 등과 같은 정신병적 증상의 치료 효과, 성적 능력 강화, 당뇨 및 천식 치료 효과를 볼 수 있고, 1일 권장량은 2.5 내지 5mg이다.Manganese (Mn) contributes to the activation of various enzymes, and deficiency causes diabetes symptoms due to weight loss, dermatitis, nausea or vomiting, discoloration of hair, decreased fertility or reduced pancreatic function. The treatment effect of psychotic symptoms such as mood swings or schizophrenia, sexual enhancement, diabetes and asthma treatment effect can be seen, the daily recommended amount is 2.5 to 5mg.
셀레늄(Se)은 천연토코페롤의 1,970배에 이르는 항산화력을 가지고 있으며, 결핍시에는 암, 심장질환, 면역기능 저하, 적혈구 기능저하, 근육통, 심근 퇴하, 근긴장 증강, 췌장기능 퇴하 등이 유발되며, 효능으로는 중금속의 무독화, 항산화작용, 항노화, 항암, 심장혈관질환 예방, 간경화 예방, 염증성 질환 예방, 당뇨병 합병증 예방, 간장 및 신장의 기능 강화, 생식기능 강화, 백내장 예방, 면역기능 향상 등의 효과를 볼 수 있고, 1일 권장량은 50 내지 200㎍이다.Selenium (Se) has 1,970 times the antioxidant power of natural tocopherol, and deficiency causes cancer, heart disease, decreased immune function, red blood cell function, muscle pain, myocardial decline, muscle tone enhancement, and pancreatic function decline. Benefits include detoxification of heavy metals, antioxidant activity, anti-aging, anti-cancer, prevention of cardiovascular disease, prevention of liver cirrhosis, prevention of inflammatory diseases, prevention of complications of diabetes, enhancement of liver and kidney function, enhancement of reproductive function, prevention of cataracts, improvement of immune function, etc. The effect of can be seen, the recommended daily amount is 50 to 200 μg.
아연(Zn)은 모든 체세포안에 있으며, 200개가 넘는 효소들의 구성성분으로서, 결핍시에는 태아의 기형발생 유발, 수면 및 행동장애, 여드름 또는 피부염 발생, 알코올성 간경화, 염증성 장질환, 자폐증 또는 정신병 등이 유발되며, 효능으로는 태아성장 촉진, 정자 형성 촉진, 피부 저항력 강화 및 피부염 치료, 성장 발육 촉진, 인슐린 분비 증강, 동맥경화 예방 또는 갑상선 가능 조절 등의 효과를 볼 수 있고, 1일 권장량은 15mg이다.Zinc (Zn) is found in all somatic cells and is a constituent of more than 200 enzymes that, when deficient, cause fetal malformations, sleep and behavioral disorders, acne or dermatitis, alcoholic cirrhosis, inflammatory bowel disease, autism or psychosis. Efficacy in promoting fetal growth, sperm formation, enhancing skin resistance and treating dermatitis, promoting growth and development, increasing insulin secretion, preventing atherosclerosis, or controlling the thyroid gland. The recommended daily dose is 15mg. .
인(P)은 칼슘 다음으로 체내에 많은 무기질로 인체의 전체 미네랄 중 22%를 차지하며, 에너지의 저장과 방출에 관여하고 인지질과 리포단백의 구성성분이며 세포의 구조와 기능에 중요한 역할을 하고, 핵산의 보조효소로도 작용한다. 결핍시에는 ATP 합성 저하로 무기력해지며, 유아의 체중 감소, 구루병, 성인의 골연화증이 유발되며, 효능으로는 칼슘과 결합하여 구루병과 골연화증을 예방하고 많은 비타민 B와 결합하여 효소활성을 가지며, 1일 권장량은 800mg이다.Phosphorus (P) is the second largest mineral in the body after calcium. It is responsible for 22% of the total minerals in the human body. It is involved in the storage and release of energy, is a component of phospholipids and lipoproteins, and plays an important role in the structure and function of cells. It also acts as a coenzyme for nucleic acids. In case of deficiency, it becomes lethargic due to a decrease in ATP synthesis, weight loss in children, rickets disease, osteomalacia in adults, and efficacy in combination with calcium to prevent rickets and osteomalacia, and in combination with many vitamin B has enzymatic activity, 1 The recommended daily dose is 800 mg.
칼륨(K)은 성인의 체내총량이 150g 정도로 세포내액의 산, 알카리 평형에 가장 중요한 미네랄이며, 결핍시에는 부정맥, 저혈당, 무력증 등이 유발되며 효능으로는 정상 체액유지와 공급, 인체의 정상적인 산염기 균형유지, 정상적인 근육반응 유지, 정상적인 삼투압 유지, 혈관 확장, 인슐린 분비 촉진, 심근경색의 방어효과를 볼 수 있고, 1일 권장량은 3,600 내지 10,000이다.Potassium (K) is the most important mineral for the balance of acid and alkali in the intracellular fluid, with an adult total body weight of 150g. When deficient, arrhythmias, hypoglycemia and asthenia are induced. Maintain base balance, maintain normal muscle reaction, maintain normal osmotic pressure, vasodilation, promote insulin secretion, defense of myocardial infarction, the recommended daily dose is 3,600 to 10,000.
칼슘(Ca)은 체내 무기질 중 가장 양이 많은 원소로, 매일 700mg 정도의 칼슘이 뼈와 혈액사이를 이동한다. 결핍시에는 혈액속의 칼슘저하로 말초신경과 근육접합부의 흥분성이 높아져 가벼운 자극으로 근육, 주로 손, 발, 안면근육이 수축 및 경련을 일으키는 테타니증이 유발되며, 효능으로는 골다공증, 구루병, 골절, 충치, 퇴행변성 관절증의 치료효과, 고혈압, 동맥경화증, 설사 또는 당뇨의 예방, 알레르기 질환 또는 감기 예방, 불면증, 신경과민의 치료, 심근 수축력의 증강, 신경 및 근육의 흥분, 혈액응고작용의 촉진 효과를 볼 수 있고, 1일 권장량은 1내지 1.2g이다.Calcium (Ca) is the most abundant element in the body's minerals, about 700 mg of calcium between the bones and the blood every day. In deficiency, the lowering of calcium in the blood increases excitability of peripheral nerves and muscle junctions, resulting in mild stimulation, which causes tetanosis, which causes muscles, mainly hands, feet, and facial muscles to contract and cramp.These include osteoporosis, rickets, fractures, Treatment of tooth decay, degenerative arthrosis, prevention of hypertension, arteriosclerosis, diarrhea or diabetes, prevention of allergic diseases or colds, insomnia, nerve hypersensitivity, strengthening myocardial contractility, excitement of nerves and muscles, promoting blood coagulation You can see, the recommended daily amount is 1 to 1.2g.
철(Fe)은 헤모글로빈 속에 함유되어 산소와 결합하는 데 중요한 역할을 하는데, 철분이 부족하면 헤모글로빈을 생성할 수 없어서 적혈구도 보통보다 작아지게 되며 안색이 나빠지고, 쉽게 피로해지며 철분의 균형을 잃게 되어 빈혈이 유발된다.Iron (Fe) is contained in hemoglobin and plays an important role in binding to oxygen. When iron is insufficient, hemoglobin cannot produce hemoglobin, causing red blood cells to become smaller than normal, making the complexion worse, fatigue, and unbalanced iron. Anemia is caused.
해수에는 상기 언급된 구리, 나트륨, 마그네슘, 망간, 셀레늄, 아연, 인, 칼륨, 칼슘, 철 등이 다량 함유되어 있고, 이 외에도 인체에 필수적인 영양소인 미량의 원소가 균형있게 함유되어 있다고 알려져 있다.It is known that seawater contains a large amount of copper, sodium, magnesium, manganese, selenium, zinc, phosphorus, potassium, calcium, iron, and the like mentioned above, and a balanced amount of trace elements which are essential nutrients to the human body.
해수는 표층수와 구별하여 해양 심층수라고 불려지고 있는데, 해양 심층수라는 것은 해수 표면으로부터 200미터 이하의 해수를 일컫는 것으로서, 광합성이 일어나지 않아 식물성장에 필요한 질소, 인, 규산 등의 무기영양소를 많이 포함하고 있으며, 대기나 화학물질에 의한 오염 및 일반세균에 오염되지 않으므로 해양성 세균수도 적어 물리적 청정성도 매우 뛰어나며, 필수 미량원소와 다양한 미네랄이 균형있게 포함되어 있고, 또한 4대 미네랄(마그네슘, 칼슘, 칼륨, 나트륨)외 아연, 셀렌, 망간 등을 포함하여 스트레스나 체질 불량 등으로 발생되는 각종 질병에 대한 면역기능도 우수하며, 식수로 사용하는 지표수나 지하수 등에 비해 청정도가 매우 뛰어난 것으로 알려져 있다. 해양 오염이 심각한 현재의 상태에서 표층수는 식음료로 적합하지 않으나, 해양심층수는 표면층에 비하여 생균수가 그다지 많지 않을뿐더러 병원성 생물이 조금도 포함되어 있지 않기 때문에 음료로 선택하는 경우에 안전성이 지극히 높다고 할 수 있다(일본공개특허공보 평5-219921호).Seawater is called deep seawater, which is distinguished from surface water, and deep sea water refers to seawater less than 200 meters from the surface of seawater. It contains many inorganic nutrients such as nitrogen, phosphorus, and silicic acid needed for plant growth because photosynthesis does not occur. Because it is not polluted by air or chemicals or general bacteria, it has a small number of marine bacteria, so it has excellent physical cleanliness. It also contains a balance of essential trace elements and various minerals, and also has four minerals (magnesium, calcium, potassium, sodium). It is also known to have excellent immunity against various diseases caused by stress or constitution, including zinc, selenium, manganese, etc., and it is known to have excellent cleanliness compared to surface water or groundwater used for drinking water. In the current state of serious marine pollution, surface water is not suitable for food and beverage, but since deep sea water does not have a lot of viable bacteria and does not contain any pathogenic organisms compared with surface layer, it is very safe to choose as a drink. (JP-A-5-219921).
이러한 해양 심층수의 특징은 태양광이 도달하지 않는 심해에서는 영양 물질을 소비하는 식물 플랑크톤이 없기 때문에 박테리아 등에 의하여 분해된 영양물질이 풍부하고 칼슘, 마그네슘 등의 미네랄이 다량 포함되어 있는 부영양성(미네랄 성)이 있고, 표면 해수로부터 200미터 이하에는 유기물의 농도가 낮고, 대장균 또는 일반세균에 의한 오염이 없으며, 육지나 대기로부터의 화학물질에 의한 오염의 가능성도 적은 청정성을 갖고 있으며, 일년 내내 저온으로 그 변화가 적고 안정된 낮은 수온성을 갖고, 해양 심층수는 수천년 동안 형성된 물이기 때문에 그 성질이 안정되어 있으며, 각종 효소들의 작용으로 인하여 숙성화 되어 있는 숙성성을 갖고 있으며, 필수 미량원소나 다양한 미네랄 성분이 균형있게 포함되어 있어 용존되어 있는 금속이온들의 작용으로 활성 산소에 대한 탁월한 소거작용 효과 등의 특성으로 갖고 있다고 알려져 있다. The characteristics of deep ocean water are eutrophic (mineral) which is rich in nutrients decomposed by bacteria and contains a large amount of minerals such as calcium and magnesium because there is no phytoplankton that consumes nutrients in the deep sea where sunlight does not reach. ), Less than 200 meters from the surface seawater, low concentration of organic matter, no contamination by E. coli or common bacteria, and less cleanliness, less likely to be polluted by chemicals from land or air, It has little change and stable low water temperature, and since the deep sea water is water which has been formed for thousands of years, its properties are stable, and it is matured due to the action of various enzymes, and essential trace elements and various mineral components Of these dissolved metal ions It is known to have properties such as an excellent scavenging effect on active oxygen.
이러한 해양심층수는 해수를 가열 농축하고 그 농축액을 냉각한 후, 농축액으로부터 얻어진 결정분을 제거하고, 이를 농축액의 부피가 원래 부피의 1/1000이하로 농축될 때까지 지속시켜 얻어지는 것을 특징으로 하는 건강증진액 및 그 제조방법을 기재하고 있고 그 용액 일부를 음료수에 가함으로써 당뇨병, 알레르기성 질환, 심근경색 등의 현대병의 예방에 유효한 건강음료를 개시하고 있다(일본공개특허공보 제 평6-209739호).This deep sea water is obtained by heating and concentrating the seawater, cooling the concentrate, and then removing the crystals obtained from the concentrate, and continuing it until the volume of the concentrate is concentrated to less than 1/1000 of the original volume. It describes the enhancement solution and its manufacturing method, and discloses a health drink effective for the prevention of modern diseases such as diabetes, allergic disease, myocardial infarction, etc. by adding a portion of the solution to the beverage (Japanese Patent Laid-Open No. 6-209739). ).
또한 이 해양 심층수에 염화나트륨 등의 전해질을 가하여 전기분해장치에서 전기분해를 시행하여 그 양극쪽으로부터 얻어진 강산성 산화수(pH 2.4 내지 2.7이하에서 산화환원전위가 1000mV 이상)와 음극쪽으로부터 얻어진 알칼리 환원수가 알려져 있는데, 강산성 산화수의 용도로서는 그 산화력과 산성에 의한 살균작용으로 이용하여 의료용 기구의 소독살균 및 식품의 살균소독에 이용되어 왔다. 알칼리 환원수에 대해서는 위장내의 이상발효, 만성설사, 소화불량, 제산 및 위산과다 등의 위장질환에 대하여 효능이 있다고 알려져 있다(일본공개특허공보 제2001-198575호 참조).In addition, an electrolyte such as sodium chloride is added to the deep sea water and subjected to electrolysis in an electrolysis device. The strongly acidic oxidation water obtained from the positive electrode side (the redox potential is higher than 1000 mV at pH 2.4 to 2.7 or lower) and the alkali reduced water obtained from the negative electrode side are known. However, the use of strongly acidic oxidized water has been used for disinfection sterilization of medical instruments and sterilization of food by using the oxidizing power and sterilization action by acid. Alkaline reduced water is known to be effective against gastrointestinal diseases such as abnormal fermentation, chronic diarrhea, indigestion, antacids, and excessive stomach acid in the stomach (see Japanese Patent Application Laid-Open No. 2001-198575).
또한 해양 심층수에 함유된 미네랄 성분에 중점하여 미네랄 성분으로서 종래에 알려진 칼슘, 마그네슘 이외에 동, 아연 등의 금속이나 요소 등의 필수 미네랄 성분이 확인되었고, 생균수가 표층수보다 적기 때문에 이 심층수를 천연 미네랄수로 음료수에 첨가하여 미네랄 음료로서도 개발된 바 있다(일본공개특허공보 평5-219921호).In addition to the mineral components contained in the deep sea water, essential minerals such as metals and urea, such as copper and zinc, in addition to calcium and magnesium, which have been previously known as minerals, have been identified. It has also been developed as a mineral drink in addition to soda (Japanese Patent Laid-Open No. 5-219921).
해양 심층수에는 4대 미네랄(마그네슘, 칼슘, 칼륨, 나트륨), 아연, 망간 등을 포함하여 스트레스나 체질 불량 등으로 발생되는 각종 질병에 대한 면역기능도 우수하며, 이처럼 미량원소나 다양한 미네랄 성분에 균형있게 포함되어 있어 용존되어 있는 금속이물 등의 작용으로 활성산소에 대한 탁월한 소거작용 효과 등의 특성을 갖고 있다는 것이 이미 알려져 있다.The deep sea water also has excellent immunity against various diseases caused by stress or constitution, including four major minerals (magnesium, calcium, potassium, sodium), zinc, and manganese. It is already known that it has properties such as an excellent scavenging effect on active oxygen by the action of dissolved metal foreign matter and the like.
또한 이 심층수를 역삼투압 장치를 이용하여 담수(淡水)화된 물에 해수를 취하여 얻어진 쓴 맛의 즙과 광산(鑛酸)을 첨가한 음료도 알려져 있다(일본공개특허공보 평10-150960호).Moreover, the drink which added the bitter juice and mine obtained by taking sea water to the fresh water which was made into this fresh water using a reverse osmosis apparatus is known (Japanese Patent Laid-Open No. 10-150960).
그러나, 상기한 제조공정들은 역삼투압이나 전기분해 등의 증발농축 단계를 필수적으로 거치기 때문에 미네랄 농축액과 미네랄분이 희박하거나 함유되지 않는 물도 생산될 수 있는 등의 문제점이 있어, 광천수로부터 미네랄 성분을 제거한 물에 탈염 처리하여 얻어진 심층수로부터 얻은 미네랄 성분을 첨가한 광천수 음료에 대한 연구도 시행된 바가 있다(일본공개특허공보 제2001-190256호).However, the above-mentioned manufacturing processes have a problem such that mineral concentrate and lean water may be produced because the essential steps go through evaporation concentration step such as reverse osmosis or electrolysis, thus removing water from mineral water. The mineral water drink which added the mineral component obtained from the deep water obtained by the desalting process was also performed (Japanese Patent Laid-Open No. 2001-190256).
이러한 심층수는 아토피성 피부병 등의 피부치료를 위한 겔 제제로서 개발되거나(일본공개특허공보 평9-110702호), 두부 등과 같은 식품가공품 및 의약부외품 등에 배합하거나(일본공개특허공보 평9-28269호), 이 해양 심층수를 기본구성으로 하여 원료액즙, 당질원료, 부원료, 음료용수 등을 가하여 건강음료로 개발하거나(일본공개특허공보 제5-219921호), 빵을 만드는 공정 중에 사용하는 제조공정 중에 사용되는 수분 또는 액체로서 심층수를 사용하는 제조방법 등이 연구된 바 있다(일본공개특허공보 제2000-333592호).Such deep water is developed as a gel preparation for skin treatment such as atopic dermatitis (Japanese Patent Application Laid-Open No. 9-110702), or blended into food processed products such as tofu, and quasi-drug products (Japanese Patent Laid-Open Publication No. 9-28269). Based on this deep sea water, it is developed as a health beverage by adding raw material juice, sugar raw materials, side materials, and drinking water (Japanese Patent Publication No. 5-219921), or during the manufacturing process used during the bread making process. A manufacturing method using deep water as a water or liquid to be used has been studied (Japanese Patent Laid-Open No. 2000-333592).
타우린(Taurine)Taurine
타우린은 아미노산의 일종으로 새우, 오징어, 문어, 조개류등과 갑각류 및 연체동물에 많이 함유되어 있으며, 주된 생리작용은 담즙생성, 콜레스테롤의 농도조절, 이온의 세포막투과조절, 항산화작용, 과도한 신경흥분억제작용이 있으며, 체액보다는 심장과 골격근, 뇌, 생식기관의 세포등에 많이 함유되어 있다. 타우린은 심장의 칼슘이온 농도가 정상보다 낮을 때 심장의 수축력을 약화시킴으로 강심작용이 있는 것으로 알려져 있으며, 담즙산과 중합체를 형성하여 담즙산의 독성을 완화하고 장에서 지방흡수를 돕는다. 한편 카테콜아민이 지방조직을 분해하는 과정에 관여하여 지방대사를 촉진하며, 콜레스테롤과 중성지방을 감소시켜 혈압을 정상으로 유지하므로 동맥경과, 고혈압, 뇌졸중, 심부전등의 성인병에도 효과가 있는 것으로 알려져 있다 세포막에서는 과산화물과 질소산화물, 후리라디칼이 세포막에 손상을 주기 전에 제거함으로 새포를 보호한다. 타우린은 뇌에 들어 있는 아미노산중 농도가 가장 높으며, 신경이 지속적으로 흥분될 때 과도한 신경흥분을 억제하여 신경안정효과도 있는 것으로 알려져 있다.Taurine is a kind of amino acid and is contained in shrimp, squid, octopus, shellfish and shellfish and mollusks.The main physiological functions are bile formation, cholesterol concentration control, ion permeability, antioxidant activity, and excessive neurostimulation. There is a function, rather than body fluids in the heart, skeletal muscle, brain, reproductive organs and cells are contained. Taurine is known to have a cardiac effect by weakening the contractile force of the heart when the calcium ion concentration in the heart is lower than normal, and forms bile acids and polymers to reduce the toxicity of bile acids and help intestinal fat absorption. Meanwhile, catecholamines are involved in the process of decomposing fat tissues, promoting fat metabolism, and reducing cholesterol and triglycerides to maintain normal blood pressure, which is known to be effective in adult diseases such as arterioscopy, hypertension, stroke, and heart failure. Protects the cells by removing peroxides, nitrogen oxides and free radicals before damaging the cell membrane. Taurine has the highest concentration of amino acids in the brain and is known to have a neurostable effect by inhibiting excessive excitement when the nerves are constantly excited.
비타민 류Vitamins
비타민은 체외로부터 섭취하는 식품중 주영양소인 답백질, 탄수화물 및 지방, 무기염류 및 수분이외에 동물의 정상적인 발육과 영양을 보존하기 위한 필수불가결한 미량물질의 총칭이다. 비타민류에는 수용성 비타민으로 비타민 B1(치아민), 비타민 B2(리보플라빈), 니코틴산 아미드, 비타민 M(엽산), 비타민 B6(피리독신), 비타민 B12(시아노코발아민), 비타민 H(비오틴), 비타민 C(아스코르빈산) 등이 있으며, 지용성 비타민으로서는 비타민 A, 비타민 D(칼시페롤), 비타민 E(토코페롤), 비타민 K(피로키논), 비타민 F(리놀렌산) 등이 있다. Vitamin is a general term for essential trace substances for preserving the normal development and nutrition of animals other than the main nutrients such as protein, carbohydrates and fats, inorganic salts and water. Vitamins include water-soluble vitamins such as vitamin B 1 (chiamine), vitamin B 2 (riboflavin), nicotinic acid amide, vitamin M (folic acid), vitamin B 6 (pyridoxine), vitamin B 12 (cyanocobalamine), and vitamin H (biotin). ), Vitamin C (ascorbic acid), and the like, and fat-soluble vitamins include vitamin A, vitamin D (calciferol), vitamin E (tocopherol), vitamin K (pyrokinone), and vitamin F (linolenic acid).
비타민 C는 수용성 비타민으로써 체내 여러 가지 물질의 합성에 관여하여 혈관, 뼈, 피부 등 인체 결합조직에 꼭 필요한 항산화 물질이다. Vitamin C is a water-soluble vitamin that is involved in the synthesis of various substances in the body and is an essential antioxidant for human connective tissue such as blood vessels, bones and skin.
특히, 콜라겐 형성을 촉진, 피부의 탄력 유지, 항산화작용으로 유해산소로부터 인체를 보호하여 피부미용, 피로회복, 기미, 주근깨 등에 좋다고 알려져 있다. In particular, it promotes collagen formation, maintains skin elasticity, and protects the human body from harmful oxygen by its antioxidant action, which is known to be good for skin beauty, fatigue recovery, blemishes, freckles and the like.
비타민 B군(복합비타민)은 유기물질로서 대사기능을 수행하기 위하여 인체에서 일어나는 여러 생리작용을 원활하게 하는 효소를 만드는 중요한 역할을 하며 그 중 비타민 B군은 에너지 대사에 깊이 관여되어 있는 성분으로 스트레스나 피로감을 자주 느끼는 지친 현대인들의 건강관리에 필수적인 영양소이다. Vitamin B group (combined vitamin) is an organic substance that plays an important role in making enzymes that facilitate various physiological functions in the human body in order to perform metabolic functions. Among them, vitamin B group is a component that is deeply involved in energy metabolism. It is an essential nutrient for the health management of tired modern people who often feel tired.
로얄제리Royal Jelly
로얄제리는 꿀벌 유충의 영양섭취에 사용되는 꿀벌의 분비물이며, 여왕벌의 주식이기도 하다. 꿀벌이 밀랑에 담아서 체내의 효소로 과당과 포도당으로 전화하여 농축해 저장한 일종의 벌꿀류이며 독특한 향기와 맛을 지니고 있으며 독일에서는 “여왕의 숲”이라고 불리기도 한다. Royal jelly is a secretion of honeybees used to nourish honeybee larvae and is a staple food for queen bees. Bees are a type of honey that honeybees have stored in Milan and use enzymes in the body to convert fructose and glucose and store it. It has a unique aroma and taste, and in Germany it is called the "queen's forest."
주 기능으로는 인체의 면역력을 증강시켜주고 영양이 풍부하여 몸이 약한 사람은 회복을 촉진시키는데 도움을 주며 성질이 따뜻해 위장건강에도 좋으며 피부미용, 갱년기 장애, 피로회복에도 효과적이다. 또한 로얄제리는 널리 사용되는 안전성이 확보되어 있어 누구나 섭취가 가능한 자연식품으로 각광받고 있다. Its main function is to enhance the immunity of the human body, and it is rich in nutrition, which helps the weak body to promote recovery, and its warm nature is good for gastrointestinal health, and it is also effective for skin beauty, menopausal disorders and fatigue recovery. In addition, Royal Jelly is widely used as a natural food that anyone can consume because it has a widely used safety.
프로폴리스Propolis
프로폴리스는 꿀벌이 자신의 생존과 번식을 위해 여러 식물에서 뽑아낸 수지(樹脂)와 같은 물질에 자신의 침과 효소 등을 섞어서 만든 물질로, 미네랄?비타민?아미노산?지방?유기산?플라보노이드 등은 세포대사에 중요한 역할을 하며, 항염 ? 항산화 ? 면역증강 등에 도움을 준다고 알려져 있다. 프로폴리스는 유해한 바이러스, 세균, 곰팡이, 효모 및 버섯의 증식을 억제하는 작용이 있으며, 바이러스가 원인이되는 감기, 독감, 위염, 위궤양, 당뇨, 대상포진등에 효과가 있으며, 세균이 윈인이 되는 식중독, 비염, 장염, 화농성 질환, 구내염, 치주염, 상처, 화상등 및 효모와 곰팡이가 원인이되는 피부질환에도 효과가 있는 것으로 보고되어 있다.Propolis is made by mixing bees and enzymes with resin-like substances extracted from various plants for the survival and reproduction of bees. Minerals, vitamins, amino acids, fats, organic acids, flavonoids, etc. Plays an important role in cell metabolism, anti-inflammatory? Antioxidant? It is known to help boost immunity. Propolis has the effect of inhibiting the proliferation of harmful viruses, bacteria, fungi, yeasts and mushrooms, and is effective against colds, flu, gastritis, gastric ulcers, diabetes, shingles, etc. It has been reported to be effective against rhinitis, enteritis, purulent diseases, stomatitis, periodontitis, wounds, burns, and skin diseases caused by yeast and mold.
본 발명은 상기의 많은 특징을 가진 해양심층수에 활성산소와 연계된 항산화작용이 강한 다양한 성분으로 구성된 조성물에 관한 구체적인 연구는 없었다.In the present invention, there is no specific study on a composition composed of various components having strong antioxidant activity associated with active oxygen in deep sea water having many of the above characteristics.
항산화작용과 직결되는 활성산소란 원래 인간을 비롯한 동,식물의 체내의 있으면서 곰팡이, 바이러스, 이물질 등이 체내에 진입했을 때 이를 죽이거나 용해시켜 살균하는 화학물질이다. 그러나 이 활성산소가 체내에 지나치게 증가되며 오히려 자기 몸의 조직을 공격하는 양면성을 지니고 있다. 따라서 우리 몸안에는 체내에서 생성된 유해한 활성산소를 제거하기 위해 항산화벽(항산화 방어 메커니즘)이 존재 한다. 즉 인간의 체내에는 SOD(수퍼옥시드 디스뮤타제)같은 효소를 비롯해 각 종 항산화물질이 존재해 활성산소의 공격으로부터 인체를 방어해주고 있다. 더 자세하게 세포안에서는 셀레늄과 클루타티온으로 만들어지는 글루타치온 페록시다제와 아연, 구리, 망간 등을 필요로 하는 SOD라고 불리우는 수퍼옥시드디스무타아제, 카탈리아제 효소에 의해 활성산소가 제거된다. 통상 우리가 호흡하는 산소의 2-5%정도는 활성산소로 바뀌어지는데 문제가 되는 것을 인체내 항산화벽을 뛰어넘을 정도로 생성되는 과잉현상이다. 이의 원인으로 1)스트레스 2)자외선 3)방사선 4)화학물질(농약, 살충제, 의약품, 질소 화합물) 5)과격한 운동(힘든 육체 노동), 과식, 음주, 흡연 6)각종 공해 등이다. 현대의 과도한 스트레스의 환경에서는 생체 내 활성산소의 생성과 제거의 균형이 많이 깨어지고 있어 스트레스를 해소시켜주거나 또는 항산화 성분이나 항산화 성분 생성에 필요한 미네랄성분을 외부로부터 보급해주는 것이 아주 중요하다. 한편, 신경을 안정시켜 스트레스 해소에 도움을 주는 칼슘 등의 성분을 섭취해주는 것도 중요하다.Active oxygen, which is directly related to antioxidant activity, is a chemical that kills or dissolves fungi, viruses, and foreign substances when it enters the body while being in the body of animals and plants including humans. However, this free radical is excessively increased in the body, and rather has a double-sided attack on the tissues of the body. Therefore, there is an antioxidant wall (antioxidant defense mechanism) in our body to remove harmful free radicals produced in the body. In other words, enzymes such as SOD (superoxide dismutase) and various antioxidants exist in the human body to protect the body from attack of free radicals. More specifically, in the cell, free radicals are removed by glutathione peroxidase made of selenium and glutathione, and superoxide dismutase and catalase enzymes called SODs that require zinc, copper, and manganese. Normally, 2-5% of the oxygen we breathe is a surplus that exceeds the antioxidant walls in the body, causing the problem of turning into free radicals. This can be caused by: 1) stress 2) ultraviolet radiation 3) radiation 4) chemicals (pesticides, pesticides, medicines, nitrogen compounds) 5) intense exercise (hard physical labor), overeating, drinking and smoking 6) pollution. In the environment of excessive stress in modern times, the balance between the generation and removal of free radicals in the living body is broken, so it is very important to relieve stress or to disperse the minerals necessary for the production of antioxidants or antioxidants from the outside. On the other hand, it is also important to eat ingredients such as calcium to stabilize the nerves to help relieve stress.
해양심층수를 이용하여 각종 식품의 제조방법, 음료수의 제조방법이 나와 있으나 심신안정, 항스트레스, 항피로 등 인체의 면역능 증강에 큰 효과를 주는 기능성 음료조성물 관련 내용은 나와 있지 않았다.There is a method of manufacturing various foods and drinks using deep sea water, but there is no information on functional beverage composition which has a great effect on the body's immunity enhancement such as mental and physical stability, antistress and anti-fatigue.
이에 본 발명은 항산화작용이 강한 비타민C에 항산화성분 생성에 필요한 다양한 미네랄 성분인 해양심층수에 면역능, 항피로, 간기능활성화 등에 주목되는 타우린, 로얄제리, 프로폴리스, 비타민 B군의 이상적인 조성물로 구성된 것이다.Therefore, the present invention is composed of taurine, royal jelly, propolis, vitamin B group, which is focused on vitamin C, which has strong antioxidant activity, and attention to immunity, anti-fatigue, liver function activation, etc. will be.
해양심층수와 타우린, 비타민류, 로얄제리 및 프로폴리스를 주성분으로 함유하는 기능성 음료 조성물은 개발된바 없으며, 본 발명에 의하여 해양심층수, 타우린, 비타민류, 로얄제리 및 프로폴리스를 함유하는 기능성 음료 조성물을 제공함으로서 통상의 식사로는 부족되기 쉬운 다양한 미네랄 성분을 공급하고, 스트레스해소, 심신 안정, 간장활동 촉진, 활달한 담즙분비, 간장해독기능 증강, 및 활성화 시킬 수 있는 가능성 음료 조성물을 제공하는 것이 본 발명의 목적이다.A functional beverage composition containing deep sea water and taurine, vitamins, royal jelly and propolis has not been developed. The functional beverage composition containing deep sea water, taurine, vitamins, royal jelly and propolis has not been developed by the present invention. By providing a variety of minerals that are likely to be lacking in the normal diet, by providing a beverage composition that can relieve stress, stabilize mind and body, promote liver activity, stimulate bile secretion, enhance liver detoxification function, and activate. It is an object of the invention.
본 발명의 주성분의 하나인 해양심층수는 일반 식음료에서는 얻을 수 없는 부족한 미네랄 성분들을 용이하게 섭취하고, 신체의 미네랄 균형을 보완해 주는 천연미네랄 건강음료로서 간장기능을 증강시키는 타우린, 항산화, 항피로제로 주목받는 비타민B2, 니코틴산아미드, 비타민C, 로얄제리, 프로폴리스를 보강함으로서 독특한 효능을 발휘하는 기능성 음료 조성물을 개발한 것이다.Deep sea water, one of the main components of the present invention, is a natural mineral health drink that easily ingests scarce mineral components not obtained in general food and beverage, and complements the body's mineral balance, as taurine, antioxidant, and anti-fatigue agent. It has developed a functional beverage composition that exhibits unique effects by reinforcing the attention of vitamin B 2 , nicotinic acid amide, vitamin C, royal jelly, and propolis.
본 발명에 의하여 해양심층수, 타우린, 비타민류, 로얄제리 및 프로폴리스를 주성분으로 함유하는 가능성 음료 조성물을 제공한다.According to the present invention, there is provided a feasible beverage composition containing marine deep water, taurine, vitamins, royal jelly, and propolis as main ingredients.
또한 본 발명에서는 해양심층수, 타우린, 비타민류, 로얄제리 및 프로폴리스 의 주성분 이외에 보조성분으로서 구연산, 구연산나트륨, 자몽종자 추출물, 액상 과당, 스테비오사이드, 염화나트륨, 파인애플후레바를 함유할 수 있으며 기타 감미제, 유기산 또는 그 금속염, 글리세린, 점도 조절제, 향료, 과일주스에서 선택된 1종 이상의 성분을 더 함유할 수 있다.In addition, the present invention may contain citric acid, sodium citrate, grapefruit seed extract, liquid fructose, stevioside, sodium chloride, pineapple freva and other sweeteners as auxiliary components in addition to the main components of deep sea water, taurine, vitamins, royal jelly and propolis It may further contain at least one component selected from organic acids or metal salts thereof, glycerin, viscosity modifiers, fragrances, fruit juices.
본 발명에서는 비타민류로 수용성 비타민으로 비타민 B1(치아민), 비타민 B2(리보플라빈), 니코틴산 아미드, 비타민 M(엽산), 비타민 B6(피리독신), 비타민 B12(시아노코발아민), 비타민 H(비오틴), 비타민 C(아스코르빈산) 및 지용성 비타민으로서 비타민 A, 비타민 D(칼시페롤), 비타민 E(토코페롤), 비타민 K(피로키논), 비타민 F(리놀렌산)에서 선택된 3종이상의 비타민을 함유할 수 있다. 특히, 비타민 C, 비타민 B2, 니코틴산아미드를 포함한다.In the present invention, vitamin B as a water-soluble vitamin, vitamin B 1 (chiamine), vitamin B 2 (riboflavin), nicotinic acid amide, vitamin M (folic acid), vitamin B 6 (pyridoxine), vitamin B 12 (cyanocobalamine), vitamin Three or more vitamins selected from vitamin A, vitamin D (calciferol), vitamin E (tocopherol), vitamin K (pyrokinone) and vitamin F (linolenic acid) as H (biotin), vitamin C (ascorbic acid) and fat-soluble vitamins. It may contain. In particular, vitamin C, vitamin B 2 , nicotinic acid amide.
본 발명에서는 상기의 주성분이외에 보조성분의 상호작용으로 체력증진, 위장관기능 개선등의 효과를 가진다.In the present invention has the effect of improving physical strength, gastrointestinal tract function and the like by the interaction of the auxiliary components in addition to the above-mentioned main components.
본 발명에서 사용되는 상기의 보조성분들은 감미제, 유기산, 또는 그 금속염, 글리세린, 점도조절제, 향료, 과일주스등은 시판중인 성분을 사용함이 바람직하다.As the auxiliary ingredients used in the present invention, sweeteners, organic acids, or metal salts thereof, glycerin, viscosity regulators, flavorings, fruit juices, etc. are preferably used commercially available ingredients.
본 발명에서 사용되는 유기산은 구연산, 또는 그 금속염, 젖산 또는 금속염에서 선택된 1종 또는 2종 이상을 사용할 수 있다.The organic acid used in the present invention may use citric acid or one or two or more selected from metal salts, lactic acid or metal salts thereof.
본 발명에서 사용되는 향료는 허벌향, 스트로베리향 및 통상으로 사용되는 천연 또는 인공향료를 사용할 수 있다.The fragrance used in the present invention may be used herbal, strawberry and natural or artificial flavors commonly used.
본 발병에서 사용되는 과일주스는 오렌지 주스 또는 오렌지추출물, 레몬주스 또는 레몬추출물, 자몽주스 또는 자몽추출물, 사과주스 또는 사과추출물, 딸기주스 또는 딸기추출물, 복숭아주스 또는 복숭아추출물, 자두주스 또는 자두추출물, 망고주스 또는 망고 추출물 및 파파야주스 또는 파파야 추출물에서 선택된 과일주스 또는 과일추출물에서 선택된 1종 또는 2종이상을 혼합하여 사용할 수 있다.The fruit juice used in this disease is orange juice or orange extract, lemon juice or lemon extract, grapefruit juice or grapefruit extract, apple juice or apple extract, strawberry juice or strawberry extract, peach juice or peach extract, plum juice or plum extract, Mango juice or mango extract and papaya juice or papaya extract may be used by mixing one or two or more selected from fruit juice or fruit extract selected.
유기산의 금속염으로서는 나트륨염, 칼륨염, 칼슘염, 마그네슘염에서 선택된 염을 사용할 수 있다.As the metal salt of the organic acid, a salt selected from sodium salt, potassium salt, calcium salt and magnesium salt can be used.
본 발명에서는 기능성 음료조성물 100ml중에 타우린 10?1000mg, 비타민류 10?500mg, 로알제리 10?500mg 및 프로폴리스 10?500mg을 함유하며, 그 외에 보조성분을 함유하며, 나머지는 탈염 또는 부분 탈염된 해양심층수를 포함한다.In the present invention, 100 ml of functional beverage composition contains 10-1000 mg of taurine, 10-500 mg of vitamins, 10-500 mg of Roalgeria, and 10-500 mg of propolis, in addition to the auxiliary components, the rest of the desalted or partially desalted marine Includes deep water.
본 발명에서 탈염 또는 부분적으로 탈염한 해양심층수란 나트륨이온을 부분적으로 또는 전부 제거하고 다른 미네랄 성분은 그대로 잔존하는 해양심층수를 의미한다.Desalted or partially desalted deep sea water in the present invention means deep sea water that partially or completely removes sodium ions and other mineral components remain as they are.
본 발명에서는 상기의 주성분이외에 보조성분을 더 함유함할 수 있다. 본 발명에서 사용될 수 있는 보조성분으로서는 감미제, 유기산 또는 그 금속염, 글리세린, 점도조절제, 향료, 과일주스는 시판중인 성분을 사용함이 바람직하다.In the present invention, in addition to the above-mentioned main component may further contain an auxiliary component. As an auxiliary component that can be used in the present invention, it is preferable to use a commercially available sweetener, organic acid or metal salt thereof, glycerin, viscosity regulator, flavoring, fruit juice.
본 발명에서 사용되는 감미제는 D-솔비톨, 자일리톨과 같은 다가 알콜, 서당, 글루코스, 말토스, 후락토스, 이성화당과 같은 당류, 스테비오사이드, 꿀에서 선택된 1종 또는 2종이상 혼합하여 사용할 수 있다.The sweetener used in the present invention may be used in combination with one or two or more selected from polyhydric alcohols such as D-sorbitol and xylitol, sugars such as sucrose, glucose, maltose, fructose and isomerized sugar, stevioside and honey. .
본 발명에서 사용되는 유기산은 구연산 또는 그 금속염, 젖산 또는 그 금속염에서 선택된 1종 또는 2종이상을 혼합하여 사용할 수 있다.The organic acid used in the present invention may be used by mixing one or two or more selected from citric acid or metal salts thereof, lactic acid or metal salts thereof.
본 발명에서 사용되는 향료는 허벌향, 스트로베리향 및 통상으로 사용되는 천연 또는 인공향료를 사용할 수 있다. The fragrance used in the present invention may be used herbal, strawberry and natural or artificial flavors commonly used.
본 발명에서는 기능성 음료 100ml당 감미제 5g?50g을 함유할 수 있다.In the present invention may contain 5g ~ 50g sweetener per 100ml of functional drinks.
본 발명에서는 기능성 음료 100ml당 유기산 또는 유기산염 0?1.000mg을 함유할 수 있다. The present invention may contain 0 to 1.000 mg of organic acid or organic acid per 100 ml of functional beverage.
본 발명에서는 기능성 음료로서 점도를 조절하기 위하여 점도 조절제를 함유 할수 있다. 이때 사용될수 있는 점도조절제는 겔란검, 구아검, 알기닌산 나트륨염, CMC 소디움에서 선택된 점도 조절제를 사용한다.In the present invention, the functional beverage may contain a viscosity modifier to adjust the viscosity. Viscosity modifiers that can be used at this time are selected from gellan gum, guar gum, sodium alginate salt, CMC sodium.
본 발명에서는 기능성 음료 100ml당 과일주스 또는 과일추출물 적량 함유한다.In the present invention, fruit juice or fruit extract is contained in an amount per 100 ml of functional beverage.
본 발명에서는 기능성 음료의 점도를 조절하기 위하여 점도조절제를 함유할 수 있다. 이 때에 사용될 수 있는 점도조절제는 겔란검, 구아검, 알기닌산 나트륨염, CMC 소디움에서 선택된 점도조절제를 사용한다.In the present invention, to adjust the viscosity of the functional beverage may contain a viscosity modifier. Viscosity modifiers that can be used at this time use a viscosity modifier selected from gellan gum, guar gum, sodium alginate salt, CMC sodium.
본 발명에서는 보존성을 향상시키기 위하여 방부제 또는 보존제를 첨가할 수 도 있다. 이러한 방부제 또는 보존제로서는 안식향산 나트륨, p-메틸 안식향산, p-에틸안식향산, p-프로필안식향산 또는 이들의 알칼리금속나트륨을 사용할 수 있다. 그 사용량은 기능성 음료조성물 100ml당 1mg 내지 100mg을 사용할 수 있다.In the present invention, a preservative or a preservative may be added to improve the preservation. As such preservatives or preservatives, sodium benzoate, p-methyl benzoic acid, p-ethyl benzoic acid, p-propyl benzoic acid or alkali metal sodium thereof can be used. The amount can be used from 1mg to 100mg per 100ml of functional beverage composition.
본 발명은 좀더 구체적으로 기술하면 다음과 같다. The present invention is described in more detail as follows.
탈염 또는 부분적으로 탈염한 해양심층수의 제조는 그 취수지역에 따라서 미네랄의 함량에 차이가 있을 수 있다. 예를 들면, 특허등록 제 10-0854700호에 의하면, 각 취수 지역에 따른 심층수의 성분분석치는 다음의 표 1과 같다.The production of desalted or partially desalted deep sea water may vary in mineral content depending on its intake area. For example, according to Patent Registration No. 10-0854700, the component analysis value of the deep water according to each intake area is shown in Table 1 below.
표 1 TABLE 1
(고성) East Sea Deep Water
(Gosung)
(mg/ml)(mg / ml)
공개특허공보 특 2003-0066025호에 의하면, 탈염 또는 부분적으로 탈염한 해양심층수의 성상은 다음의 표 2와 같다.According to Korean Patent Laid-Open Publication No. 2003-0066025, the properties of desalted or partially desalted deep sea water are shown in Table 2 below.
표 2Table 2
상기의 표 2에서 얻어진 탈염 또는 부분적으로 탈염한 해양심층수 또는 기타 통상의 방법으로 제조된 탈염 또는 부분적으로 탈염한 해양 심층수는 본 발명에 사용될 수 있다. Desalted or partially desalted deep seawater obtained in Table 2 above or desalted or partially desalted deep sea water prepared by other conventional methods may be used in the present invention.
본 발명에서 사용되는 감미제, 유기산, 유기산의 금속염, 젖산, 젖산의 금속염, 향료, 과일 주스는 시판중인 감미제, 유기산, 유기산의 금속염, 젖산, 젖산의 금속염, 향료, 과일 주스에서 선택된 1종이상의 성분을 사용할 수 있다.The sweetener, organic acid, metal salt of organic acid, lactic acid, metal salt of lactic acid, flavoring agent, fruit juice used in the present invention are at least one component selected from commercial sweeteners, organic acids, metal salts of organic acids, lactic acid, metal salts of lactic acid, flavors, fruit juices. Can be used.
본 발명에서는 다음의 공정으로 기능성 음료조성물을 제조할 수 있다.In the present invention, the functional beverage composition can be prepared by the following process.
탱크에 탈염 또는 부분적으로 탈염한 해양심층수를 투입하고, 타우린, 비타민류, 로얄제리 및 프로폴리스를 투입하고, 필요하면 감미제, 보존제, 점도조절제, 유기산등을 투입하고 80?95℃로 가열하여 용해시킨다. 여기에 해양심층수를 더 가하여 전체를 조절한 다음 멸균한 다음 적당한 용기에 Desalted or partially desalted deep seawater is added to the tank, taurine, vitamins, royal jelly, and propolis are added. If necessary, sweeteners, preservatives, viscosity regulators, organic acids, etc. are added and heated to 80-95 ° C for dissolution. Let's do it. Add deep seawater to this and adjust the whole, then sterilize and place in a suitable container.
한다. do.
본 발명은 해양심층수, 비타민류, 타우린, 로얄제리 및 프로폴리스를 주성분으로 함유하는 기능성 음료 조성물을 제공하는 것이며, 본 발명에서는 상기 주성분이외에 구연산, 구연산나트륨, 자몽종자추출물, 액상과당, 염화나트륨 등 배합시킬 수 있으며 유기산, 감미제, 글리세린, 점도조절제, 향료, 과일주스 등에서 선택된 1종 이상의 성분을 더 함유하는 기능성 음료 조성물을 제공하는 것이며 본 발명의 기능성 음료 조성물은 통상의 식사로는 부족하기 쉬운 필수 미네랄 성분을 공급하고 간장의 활동을 촉진시키고 담즙를 활발히 하고 간장의 해독작용을 돕고 간 기능을 활성화시키며 스트레스 해소, 자연 치유력 및 면역기능 증강, 항노화작용, 피로회복 등의 효과를 가진다.The present invention is to provide a functional beverage composition containing the deep sea water, vitamins, taurine, royal jelly and propolis as a main component, in the present invention, citric acid, sodium citrate, grapefruit seed extract, liquid fructose, sodium chloride, etc. The present invention provides a functional beverage composition further comprising one or more ingredients selected from organic acids, sweeteners, glycerin, viscosity modifiers, flavorings, fruit juices, and the like. It supplies ingredients, promotes the activity of the liver, promotes bile, helps the detoxification of the liver, activates the liver function, relieves stress, enhances natural healing and immune function, anti-aging and fatigue recovery.
다음에 실시예로서 본 발명을 더욱 상세히 설명한다.Next, the present invention will be described in more detail by way of examples.
실시예 1Example 1
원료명 함량Raw Material Name Content
타우린 20mgTaurine 20mg
비타민 C 700mgVitamin C 700 mg
비타민 B2 3mgVitamin B2 3mg
니코틴산아미드 10mgNicotinamide 10mg
로얄제리 30mgRoyal Jelly 30mg
프로폴리스 50mgPropolis 50mg
사과과즙(7배농축액) 500mgApple Juice (7x Concentrate) 500mg
액상과당 19g Liquid Fructose 19g
자몽추출물 18mgGrapefruit Extract 18mg
스테베오사이드 20mgStevioside 20mg
구연산 300mgCitric acid 300mg
구연산나트륨 200mg200 mg sodium citrate
파인애플후레바 0.2mlPineapple Flavor 0.2ml
탈염 해양심층수 적량을 가하여By adding the right amount of deep desalted water
전체 100ml100 ml total
제조방법 Manufacturing method
탈염 해양심층수에 액상과당, 스테비오사이드, 타우린, 자몽종자추출물, 사과과즙7배농축액, 구연산, 구연산나트륨을 가하여 교반, 용해한 후 70℃로 냉각한다.To the desalted deep sea water, liquid fructose, stevioside, taurine, grapefruit seed extract, apple juice 7-fold concentrate, citric acid and sodium citrate are added, stirred, dissolved, and cooled to 70 ° C.
위의 액에 비타민B2 를 넣고 계속적으로 교반하여 용해한 후 40℃로 냉각한다.Add vitamin B 2 to the above solution, and continue stirring to dissolve, then cool to 40 ℃.
이 액을 40℃로 냉각한 다음 비타민C, 니코틴산아미드, 염화나트륨, 파인애플후레 바, 로얄제리, 프로폴리스를 넣고 교반하여 용해한 후 표선, 여과, 멸균하여 충전한다.After cooling this solution to 40 ℃, add vitamin C, nicotinic acid amide, sodium chloride, pineapple flavored bar, royal jelly, and propolis to dissolve it, and then fill it by marking, filtration, and sterilization.
실시예 2Example 2
원료명 함량Raw Material Name Content
타우린 500mgTaurine 500mg
비타민 C 700mgVitamin C 700 mg
비타민 B2 3mgVitamin B2 3mg
니코틴산아미드 10mgNicotinamide 10mg
비타민 B12 10IU(International Unit)Vitamin B12 10IU (International Unit)
로얄제리 100mgRoyal Jelly 100mg
프로폴리스 100mgPropolis 100mg
파인애플과즙 1000mgPineapple Juice 1000mg
액상과당 19g Liquid Fructose 19g
구연산 300mgCitric acid 300mg
구연산나트륨 200mg200 mg sodium citrate
파인애플후레바 0.2mlPineapple Flavor 0.2ml
탈염 해양심층수 적량을 가하여By adding the right amount of deep desalted water
전체 100ml100 ml total
제조방법 Manufacturing method
탈염 해양심층수에 나머지 성분들을 가하고 70℃로 가열하여 용해시킨 다음 냉각한다. 탈염 해양심층수로 표선을 조절한 후 멸균하고 충전한다.The remaining ingredients are added to the desalted deep sea water, heated to 70 ° C, dissolved, and cooled. Sterilize and fill the vessel with desalted deep sea water.
실시예 3Example 3
원료명 함량Raw Material Name Content
타우린 1000mgTaurine 1000mg
비타민 C 500mgVitamin C 500mg
비타민 B2 10mgVitamin B2 10mg
니코틴산아미드 50mgNicotinic Acid 50mg
비타민 B12 10IU(International Unit)Vitamin B12 10IU (International Unit)
로얄제리 100mgRoyal Jelly 100mg
프로폴리스 100mgPropolis 100mg
파인애플과즙 1000mgPineapple Juice 1000mg
액상과당 19g Liquid Fructose 19g
구연산 300mgCitric acid 300mg
구연산나트륨 200mg200 mg sodium citrate
파인애플후레바 0.2mlPineapple Flavor 0.2ml
탈염 해양심층수 적량을 가하여By adding the right amount of deep desalted water
전체 100ml100 ml total
제조방법 Manufacturing method
탈염 해양심층수에 나머지 성분들을 가하고 70℃로 가열하여 용해시킨 다음 냉각한다. 탈염 해양심층수로 표선을 조절한 후 멸균하고 충전한다.The remaining ingredients are added to the desalted deep sea water, heated to 70 ° C, dissolved, and cooled. Sterilize and fill the vessel with desalted deep sea water.
실시예 4Example 4
원료명 함량Raw Material Name Content
타우린 500mgTaurine 500mg
비타민 C 500mgVitamin C 500 mg
비타민 B2 3mgVitamin B2 3mg
니코틴산아미드 10mgNicotinamide 10mg
비타민 B12 10IU(International Unit)Vitamin B12 10IU (International Unit)
로얄제리 300mgRoyal Jelly 300mg
프로폴리스 200mgPropolis 200mg
파인애플과즙 1000mgPineapple Juice 1000mg
액상과당 19g Liquid Fructose 19g
구연산 300mgCitric acid 300mg
구연산나트륨 200mg200 mg sodium citrate
파인애플후레바 0.2mlPineapple Flavor 0.2ml
탈염 해양심층수 적량을 가하여By adding the right amount of deep desalted water
전체 100ml100 ml total
제조방법 Manufacturing method
탈염 해양심층수에 나머지 성분들을 가하고 70℃로 가열하여 용해시킨 다음 냉각한다. 탈염 해양심층수로 표선을 조절한 후 멸균하고 충전한다.The remaining ingredients are added to the desalted deep sea water, heated to 70 ° C, dissolved, and cooled. Sterilize and fill the vessel with desalted deep sea water.
실시예 5Example 5
원료명 함량Raw Material Name Content
타우린 500mgTaurine 500mg
비타민 C 500mgVitamin C 500 mg
비타민 B2 3mgVitamin B2 3mg
니코틴산아미드 10mgNicotinamide 10mg
비타민 B12 10IU(International Unit)Vitamin B12 10IU (International Unit)
비타민 D 50mgVitamin D 50mg
비타민 B6 10mgVitamin B6 10mg
비타민 M 10mgVitamin M 10mg
로얄제리 300mgRoyal Jelly 300mg
프로폴리스 200mgPropolis 200mg
파인애플과즙 1000mgPineapple Juice 1000mg
액상과당 19g Liquid Fructose 19g
구연산 300mgCitric acid 300mg
구연산나트륨 200mg200 mg sodium citrate
파인애플후레바 0.2mlPineapple Flavor 0.2ml
탈염 해양심층수 적량을 가하여By adding the right amount of deep desalted water
전체 100ml100 ml total
제조방법 Manufacturing method
탈염 해양심층수에 나머지 성분들을 가하고 70℃로 가열하여 용해시킨 다음 냉각한다. 탈염 해양심층수로 표선을 조절한 후 멸균하고 충전한다.The remaining ingredients are added to the desalted deep sea water, heated to 70 ° C, dissolved, and cooled. Sterilize and fill the vessel with desalted deep sea water.
실시예 6Example 6
원료명 함량Raw Material Name Content
타우린 500mgTaurine 500mg
비타민 C 500mgVitamin C 500 mg
비타민 B2 3mgVitamin B2 3mg
니코틴산아미드 10mgNicotinamide 10mg
비타민 B12 10IU(International Unit)Vitamin B12 10IU (International Unit)
비타민 D 50mgVitamin D 50mg
비타민 B6 10mgVitamin B6 10mg
로얄제리 300mgRoyal Jelly 300mg
프로폴리스 200mgPropolis 200mg
파인애플과즙 1000mgPineapple Juice 1000mg
액상과당 19g Liquid Fructose 19g
구연산 300mgCitric acid 300mg
구연산나트륨 200mg200 mg sodium citrate
파인애플후레바 0.2mlPineapple Flavor 0.2ml
탈염 해양심층수 적량을 가하여By adding the right amount of deep desalted water
전체 100ml100 ml total
제조방법 Manufacturing method
탈염 해양심층수에 나머지 성분들을 가하고 70℃로 가열하여 용해시킨 다음 냉각한다. 탈염 해양심층수로 표선을 조절한 후 멸균하고 충전한다.The remaining ingredients are added to the desalted deep sea water, heated to 70 ° C, dissolved, and cooled. Sterilize and fill the vessel with desalted deep sea water.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090017371A KR101119645B1 (en) | 2009-03-02 | 2009-03-02 | A functional beverage composition comprising deep sea water, taurine, vitamins, royal jelly and propolis as main ingredients |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090017371A KR101119645B1 (en) | 2009-03-02 | 2009-03-02 | A functional beverage composition comprising deep sea water, taurine, vitamins, royal jelly and propolis as main ingredients |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100098742A KR20100098742A (en) | 2010-09-10 |
KR101119645B1 true KR101119645B1 (en) | 2012-03-14 |
Family
ID=43005376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090017371A KR101119645B1 (en) | 2009-03-02 | 2009-03-02 | A functional beverage composition comprising deep sea water, taurine, vitamins, royal jelly and propolis as main ingredients |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101119645B1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102011101102A1 (en) * | 2011-05-10 | 2012-11-15 | Rosemarie Bort | Foodstuff comprises e.g. dry fruits e.g. figs, cereals e.g. oats, plant oils e.g. almond oil, natural flavorings e.g. cinnamon, vitamins, minerals, honey, fruit juices, milk products, water and components from bee products e.g. bee bread |
CN107535781A (en) * | 2017-08-02 | 2018-01-05 | 江苏丰海新能源淡化海水发展有限公司 | It is a kind of to contain sports drink to desalinize seawater and preparation method thereof |
KR102391878B1 (en) * | 2019-11-13 | 2022-04-29 | 재단법인 순천바이오헬스케어연구센터 | Functional beverage composition comprising extracts of fat-removed and fermented tenebrio molitor |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040028251A (en) * | 2002-09-30 | 2004-04-03 | 임 그리워 | Health Beverage composition using the concentrate of Bando Deep Ocean Water |
-
2009
- 2009-03-02 KR KR1020090017371A patent/KR101119645B1/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040028251A (en) * | 2002-09-30 | 2004-04-03 | 임 그리워 | Health Beverage composition using the concentrate of Bando Deep Ocean Water |
Also Published As
Publication number | Publication date |
---|---|
KR20100098742A (en) | 2010-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20030143311A1 (en) | Recovery drink formula and method | |
WO2008014674A1 (en) | A nutritional and health-care edible potassium salt with wide purpose | |
KR20110013685A (en) | A functional beverage comprising deep sea water, extract of fermented black ginger and extract of jujubae fructus as main ingredients | |
US20030104107A1 (en) | Energy drink formula and method | |
KR101119645B1 (en) | A functional beverage composition comprising deep sea water, taurine, vitamins, royal jelly and propolis as main ingredients | |
CN104055180A (en) | High-selenium-and-germanium enzyme beverage | |
KR20100112215A (en) | A functional beverage comprising deep sea water, extract of red ginseng, extract of jujubae fructus, extract of cnidii rhizoma, extract of glycyrrhizae radix and extract of lycii fructus as main ingredients | |
KR20100114974A (en) | A functional beverage comprising deep sea water, extract of black garlic, extract of jujubae fructus and organic acid | |
CN103932341A (en) | Soda drink containing shitake mushroom extracting solution, and preparation method thereof | |
EP1006815B1 (en) | Composition for the relief of heat stress | |
KR100482999B1 (en) | Health Beverage composition using the concentrate of Deep Ocean Water | |
US20020102313A1 (en) | Composition for the relief of heat stress | |
KR100331086B1 (en) | Tree Saps Soy and Method of Manufacturing Soy with Tree Saps | |
Das et al. | Toxic Level of Soft Drinks and Sports Drink on Health Status | |
KR20100114975A (en) | A functional beverage comprising deep sea water, black ginseng | |
US20090246322A1 (en) | Trace mineral-infused beverage to provide increased athletic performance, long-lasting energy, and health benefits | |
KR20050106631A (en) | Mineral health drink containing germanium and selenium | |
KR20100117168A (en) | A functional beverage comprising deep sea water, collagen, extract of japanese apricot and polydextrose as main ingredients | |
KR101326720B1 (en) | Mineral water composition treated by herbs and method for preparing the same | |
JP2016019536A (en) | Electrolyte reinforced composition for recharging fatigue, nutrition supplementary water and manufacturing method therefor | |
CN107751492A (en) | One kind moistens the lung and relieve the cough tea for moistening | |
JPH01157363A (en) | Tangle extract, its production and seaweed drink containing said extract | |
KR20080092045A (en) | The food break up hangover | |
KR20120119686A (en) | A functional beverage composition comprising l-arginine, vitamin c, vitamin b complex, vitamin a, vitamin e and potassium iodide as main ingredients | |
KR20180098967A (en) | cocktail for hangover remedy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |